Ignite Creation Date:
2025-12-25 @ 3:16 AM
Ignite Modification Date:
2026-01-24 @ 5:38 AM
Study NCT ID:
NCT00296205
Status:
WITHDRAWN
Last Update Posted:
2009-07-22
First Post:
2006-02-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II High-Dose Cyclophosphamide for Multiple Sclerosis
Sponsor:
Stony Brook University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
20055203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None